Determining research priorities for clinician‐initiated trials in infectious diseases
Objectives: To determine research priorities of infectious diseases physicians for clinician‐initiated randomised controlled trials (RCTs). Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand. Main outcome measures: Research priorities for,...
Gespeichert in:
Veröffentlicht in: | Medical journal of Australia 2013-03, Vol.198 (5), p.270-272 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 272 |
---|---|
container_issue | 5 |
container_start_page | 270 |
container_title | Medical journal of Australia |
container_volume | 198 |
creator | Paterson, David L |
description | Objectives: To determine research priorities of infectious diseases physicians for clinician‐initiated randomised controlled trials (RCTs).
Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
Main outcome measures: Research priorities for, and perceived barriers to, clinician‐initiated RCTs.
Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician‐initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram‐negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician‐initiated RCTs.
Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area. |
doi_str_mv | 10.5694/mja12.11703 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1317852663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1317852663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3670-97af32e34b858f2dd8f6541674ce6229cbcdb20fbb89f841298aab7b40f16033</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZP3mWPgmzN1ya7x1K_UbwU9Bay2Ymm7EdNtkhv_gR_o7_EtFWPwsDM8D68zLwIHRM8zkTBz5u5JnRMiMRsBw0JoyLNmJS7aIgxzVJJi-cBOghhHleSUbmPBpTxQnDMh-jpAnrwjWtd-5J4CKC9eU0W3nXe9Q5CYjufmDrqxun26-MzTr3TPVRJ752uQ-LaWBZM77plSCoXLQKEQ7RnowpHP32EZleXs-lNev94fTud3KeGCYnTQmrLKDBe5lluaVXlVmScCMkNCEoLU5qqpNiWZV7YnBNa5FqXsuTYEoEZG6HTre3Cd29LCL1qXDBQ17qFeI4ijMg8o0Ks0bMtanwXgger4peN9itFsFoHqTZBqk2QkT75MV6WDVR_7G9yEcBb4N3VsPrPSz3cTSiNwzfbjX96</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317852663</pqid></control><display><type>article</type><title>Determining research priorities for clinician‐initiated trials in infectious diseases</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Paterson, David L</creator><creatorcontrib>Paterson, David L ; Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network</creatorcontrib><description>Objectives: To determine research priorities of infectious diseases physicians for clinician‐initiated randomised controlled trials (RCTs).
Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
Main outcome measures: Research priorities for, and perceived barriers to, clinician‐initiated RCTs.
Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician‐initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram‐negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician‐initiated RCTs.
Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.</description><identifier>ISSN: 0025-729X</identifier><identifier>EISSN: 1326-5377</identifier><identifier>DOI: 10.5694/mja12.11703</identifier><identifier>PMID: 23496404</identifier><language>eng</language><publisher>Australia</publisher><subject>Anti-Infective Agents - therapeutic use ; Attitude of Health Personnel ; Australia ; Communicable Disease Control - methods ; Communicable Diseases - drug therapy ; Female ; Health Care Surveys ; Humans ; Infectious diseases ; Male ; Needs Assessment ; New Zealand ; Practice Patterns, Physicians ; Randomized Controlled Trials as Topic ; Research - statistics & numerical data ; Surveys and Questionnaires</subject><ispartof>Medical journal of Australia, 2013-03, Vol.198 (5), p.270-272</ispartof><rights>2013 AMPCo Pty Ltd. All rights reserved</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3670-97af32e34b858f2dd8f6541674ce6229cbcdb20fbb89f841298aab7b40f16033</citedby><cites>FETCH-LOGICAL-c3670-97af32e34b858f2dd8f6541674ce6229cbcdb20fbb89f841298aab7b40f16033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.5694%2Fmja12.11703$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.5694%2Fmja12.11703$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23496404$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paterson, David L</creatorcontrib><creatorcontrib>Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network</creatorcontrib><title>Determining research priorities for clinician‐initiated trials in infectious diseases</title><title>Medical journal of Australia</title><addtitle>Med J Aust</addtitle><description>Objectives: To determine research priorities of infectious diseases physicians for clinician‐initiated randomised controlled trials (RCTs).
Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
Main outcome measures: Research priorities for, and perceived barriers to, clinician‐initiated RCTs.
Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician‐initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram‐negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician‐initiated RCTs.
Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.</description><subject>Anti-Infective Agents - therapeutic use</subject><subject>Attitude of Health Personnel</subject><subject>Australia</subject><subject>Communicable Disease Control - methods</subject><subject>Communicable Diseases - drug therapy</subject><subject>Female</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Needs Assessment</subject><subject>New Zealand</subject><subject>Practice Patterns, Physicians</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Research - statistics & numerical data</subject><subject>Surveys and Questionnaires</subject><issn>0025-729X</issn><issn>1326-5377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZP3mWPgmzN1ya7x1K_UbwU9Bay2Ymm7EdNtkhv_gR_o7_EtFWPwsDM8D68zLwIHRM8zkTBz5u5JnRMiMRsBw0JoyLNmJS7aIgxzVJJi-cBOghhHleSUbmPBpTxQnDMh-jpAnrwjWtd-5J4CKC9eU0W3nXe9Q5CYjufmDrqxun26-MzTr3TPVRJ752uQ-LaWBZM77plSCoXLQKEQ7RnowpHP32EZleXs-lNev94fTud3KeGCYnTQmrLKDBe5lluaVXlVmScCMkNCEoLU5qqpNiWZV7YnBNa5FqXsuTYEoEZG6HTre3Cd29LCL1qXDBQ17qFeI4ijMg8o0Ks0bMtanwXgger4peN9itFsFoHqTZBqk2QkT75MV6WDVR_7G9yEcBb4N3VsPrPSz3cTSiNwzfbjX96</recordid><startdate>20130318</startdate><enddate>20130318</enddate><creator>Paterson, David L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130318</creationdate><title>Determining research priorities for clinician‐initiated trials in infectious diseases</title><author>Paterson, David L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3670-97af32e34b858f2dd8f6541674ce6229cbcdb20fbb89f841298aab7b40f16033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anti-Infective Agents - therapeutic use</topic><topic>Attitude of Health Personnel</topic><topic>Australia</topic><topic>Communicable Disease Control - methods</topic><topic>Communicable Diseases - drug therapy</topic><topic>Female</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Needs Assessment</topic><topic>New Zealand</topic><topic>Practice Patterns, Physicians</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Research - statistics & numerical data</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paterson, David L</creatorcontrib><creatorcontrib>Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical journal of Australia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paterson, David L</au><aucorp>Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determining research priorities for clinician‐initiated trials in infectious diseases</atitle><jtitle>Medical journal of Australia</jtitle><addtitle>Med J Aust</addtitle><date>2013-03-18</date><risdate>2013</risdate><volume>198</volume><issue>5</issue><spage>270</spage><epage>272</epage><pages>270-272</pages><issn>0025-729X</issn><eissn>1326-5377</eissn><abstract>Objectives: To determine research priorities of infectious diseases physicians for clinician‐initiated randomised controlled trials (RCTs).
Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
Main outcome measures: Research priorities for, and perceived barriers to, clinician‐initiated RCTs.
Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician‐initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram‐negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician‐initiated RCTs.
Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.</abstract><cop>Australia</cop><pmid>23496404</pmid><doi>10.5694/mja12.11703</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-729X |
ispartof | Medical journal of Australia, 2013-03, Vol.198 (5), p.270-272 |
issn | 0025-729X 1326-5377 |
language | eng |
recordid | cdi_proquest_miscellaneous_1317852663 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Anti-Infective Agents - therapeutic use Attitude of Health Personnel Australia Communicable Disease Control - methods Communicable Diseases - drug therapy Female Health Care Surveys Humans Infectious diseases Male Needs Assessment New Zealand Practice Patterns, Physicians Randomized Controlled Trials as Topic Research - statistics & numerical data Surveys and Questionnaires |
title | Determining research priorities for clinician‐initiated trials in infectious diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T07%3A09%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determining%20research%20priorities%20for%20clinician%E2%80%90initiated%20trials%20in%20infectious%20diseases&rft.jtitle=Medical%20journal%20of%20Australia&rft.au=Paterson,%20David%20L&rft.aucorp=Steering%20Group%20of%20the%20Australasian%20Society%20for%20Infectious%20Diseases%20Clinical%20Research%20Network&rft.date=2013-03-18&rft.volume=198&rft.issue=5&rft.spage=270&rft.epage=272&rft.pages=270-272&rft.issn=0025-729X&rft.eissn=1326-5377&rft_id=info:doi/10.5694/mja12.11703&rft_dat=%3Cproquest_cross%3E1317852663%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1317852663&rft_id=info:pmid/23496404&rfr_iscdi=true |